Societal Perspectives and Real-World Cost-Effectiveness: Expanding the Scope of Health Economics Inquiry-Reference-Cited by-同舟云学术

Societal Perspectives and Real-World Cost-Effectiveness: Expanding the Scope of Health Economics Inquiry

Published:2022-12-23 Issue:1 Volume:30 Page:233-235
ISSN:1718-7729
Container-title:Current Oncology
language:en
Short-container-title:Current Oncology

Author:

Longo Christopher J.

Abstract

Economic evaluations of health technologies for cancer are frequently seen in the literature, but not all economic perspectives have the same frequency [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/1718-7729/30/1/18/pdf

Reference8 articles.

1. Cancer premature mortality costs in Europe in 2020: A comparison of the human capital approach and the friction cost approach;Hanly;Curr. Oncol.,2022

2. Garaszczuk, R., Yong, J.H.E., Sun, Z., and de Oliveira, C. (2022). The economic burden of cancer in Canada from a societal perspective. Curr. Oncol., 12.

3. Essue, B.M., Oliveira, C.d., Bushnik, T., Fung, S., Hwee, J., Sun, Z., Navas, E.G., Yong, J.H.E., and Garner, R. (2022). The burden of health-related out-of-pocket cancer costs in Canada: A case-control study using linked data. Curr. Oncol., 12.

4. Longo, C.J. (2022). Linking intermediate to final “real-world” outcomes: Is financial toxicity a reliable predictor of poorer outcomes in cancer. Curr. Oncol., 12.

5. Bao, Y., Zhang, Z., He, X., Cai, L., Wang, X., and Li, X. (2022). Cost-effectiveness of pyrotinib plus capecitabine versus lapa-tinib plus capecitabine for the treatment of HER-2 positive metastatic breast cancer in China: A scenario analysis for health insurance coverage. Curr. Oncol., 12.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer;Familial Cancer;2024-05-25

2. The Conceptualization of Cardiometabolic Disease Policy Model in the UK;2024-02-15

3. Real-World Cost-Effectiveness Analysis: How Much Uncertainty Is in the Results?;Current Oncology;2023-04-07